HomeUSATMRW Life Sciences Raises $28M Series D Financing

TMRW Life Sciences Raises $28M Series D Financing

-

TMRW Life Sciences

TMRW Life Sciences, a NYC-based creator of the only FDA-cleared automated specimen management and storage platform for frozen human sperm, eggs and embryos, raised $28M in Series D funding.

The round was led by 5AMĀ Ventures with participation from FIOS Venture Holdings, DF Investment Partners, Transformation Capital, Life Sciences Innovation Fund, and Casdin Capital. Additional support came from actress and advocateĀ Amy Schumer, among others.

The company intends to use the funds to expand operations and its R&D sector.

Led by CEOĀ Louis Villalba, TMRW Life Sciences is a fertility technology company digitizing the IVF lab starting with automated platforms for the safe management and storage of frozen sperm, eggs and embryos. Frozen specimens can be digitally identified and tracked, safely managed with automated robotics, and remotely monitored around the clock. Its technology platforms set a new standard of care, reducing potential points of failure by 94% compared to manual systems.

The company now has more than 60 leading fertility clinic partners serving more than 39,000 patients with more than 260,000 frozen specimens under management.

FinSMEs

24/07/2024

THE DAILY NEWSLETTER - SIGNUP